世界の家族性アミロイド多発神経障害市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Familial Amyloid Polyneuropathy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2314
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、家族性アミロイド多発神経障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（FAP-I、FAP-II、FAP-III、FAP-IV）、用途別市場規模（病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・家族性アミロイド多発神経障害の市場動向
・企業の競争状況、市場シェア
・家族性アミロイド多発神経障害の種類別市場規模（FAP-I、FAP-II、FAP-III、FAP-IV）
・家族性アミロイド多発神経障害の用途別市場規模（病院・クリニック、その他）
・家族性アミロイド多発神経障害の北米市場規模2016-2027（アメリカ、カナダ）
・家族性アミロイド多発神経障害のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・家族性アミロイド多発神経障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・家族性アミロイド多発神経障害の中南米市場規模2016-2027（メキシコ、ブラジル）
・家族性アミロイド多発神経障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、GSK、Ionis、Alnylam、Corino Therapeutics、Proclara Bioscience、Arcturus Therapeutics）
・結論

Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the deposition of protein and/or amyloid fibrils around the peripheral nerves and in various tissues, including the heart muscle.
Globally, development of new drugs for treatment of familial amyloid polyneuropathy, and rise in the prevalence of familial amyloid polyneuropathy are the prime growth drivers of familial amyloid polyneuropathy market.

Market Analysis and Insights: Global Familial Amyloid Polyneuropathy Market
The global Familial Amyloid Polyneuropathy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Familial Amyloid Polyneuropathy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Familial Amyloid Polyneuropathy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Familial Amyloid Polyneuropathy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Familial Amyloid Polyneuropathy market.

Global Familial Amyloid Polyneuropathy Scope and Market Size
Familial Amyloid Polyneuropathy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Familial Amyloid Polyneuropathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
FAP-I
FAP-II
FAP-III
FAP-IV

Segment by Application
Hospitals and Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
GSK
Ionis
Alnylam
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Familial Amyloid Polyneuropathy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 FAP-I
1.2.3 FAP-II
1.2.4 FAP-III
1.2.5 FAP-IV
1.3 Market by Application
1.3.1 Global Familial Amyloid Polyneuropathy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Familial Amyloid Polyneuropathy Market Perspective (2016-2027)
2.2 Familial Amyloid Polyneuropathy Growth Trends by Regions
2.2.1 Familial Amyloid Polyneuropathy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Familial Amyloid Polyneuropathy Historic Market Share by Regions (2016-2021)
2.2.3 Familial Amyloid Polyneuropathy Forecasted Market Size by Regions (2022-2027)
2.3 Familial Amyloid Polyneuropathy Industry Dynamic
2.3.1 Familial Amyloid Polyneuropathy Market Trends
2.3.2 Familial Amyloid Polyneuropathy Market Drivers
2.3.3 Familial Amyloid Polyneuropathy Market Challenges
2.3.4 Familial Amyloid Polyneuropathy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Familial Amyloid Polyneuropathy Players by Revenue
3.1.1 Global Top Familial Amyloid Polyneuropathy Players by Revenue (2016-2021)
3.1.2 Global Familial Amyloid Polyneuropathy Revenue Market Share by Players (2016-2021)
3.2 Global Familial Amyloid Polyneuropathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Familial Amyloid Polyneuropathy Revenue
3.4 Global Familial Amyloid Polyneuropathy Market Concentration Ratio
3.4.1 Global Familial Amyloid Polyneuropathy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Familial Amyloid Polyneuropathy Revenue in 2020
3.5 Familial Amyloid Polyneuropathy Key Players Head office and Area Served
3.6 Key Players Familial Amyloid Polyneuropathy Product Solution and Service
3.7 Date of Enter into Familial Amyloid Polyneuropathy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Familial Amyloid Polyneuropathy Breakdown Data by Type
4.1 Global Familial Amyloid Polyneuropathy Historic Market Size by Type (2016-2021)
4.2 Global Familial Amyloid Polyneuropathy Forecasted Market Size by Type (2022-2027)

5 Familial Amyloid Polyneuropathy Breakdown Data by Application
5.1 Global Familial Amyloid Polyneuropathy Historic Market Size by Application (2016-2021)
5.2 Global Familial Amyloid Polyneuropathy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Familial Amyloid Polyneuropathy Market Size (2016-2027)
6.2 North America Familial Amyloid Polyneuropathy Market Size by Type
6.2.1 North America Familial Amyloid Polyneuropathy Market Size by Type (2016-2021)
6.2.2 North America Familial Amyloid Polyneuropathy Market Size by Type (2022-2027)
6.2.3 North America Familial Amyloid Polyneuropathy Market Size by Type (2016-2027)
6.3 North America Familial Amyloid Polyneuropathy Market Size by Application
6.3.1 North America Familial Amyloid Polyneuropathy Market Size by Application (2016-2021)
6.3.2 North America Familial Amyloid Polyneuropathy Market Size by Application (2022-2027)
6.3.3 North America Familial Amyloid Polyneuropathy Market Size by Application (2016-2027)
6.4 North America Familial Amyloid Polyneuropathy Market Size by Country
6.4.1 North America Familial Amyloid Polyneuropathy Market Size by Country (2016-2021)
6.4.2 North America Familial Amyloid Polyneuropathy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Familial Amyloid Polyneuropathy Market Size (2016-2027)
7.2 Europe Familial Amyloid Polyneuropathy Market Size by Type
7.2.1 Europe Familial Amyloid Polyneuropathy Market Size by Type (2016-2021)
7.2.2 Europe Familial Amyloid Polyneuropathy Market Size by Type (2022-2027)
7.2.3 Europe Familial Amyloid Polyneuropathy Market Size by Type (2016-2027)
7.3 Europe Familial Amyloid Polyneuropathy Market Size by Application
7.3.1 Europe Familial Amyloid Polyneuropathy Market Size by Application (2016-2021)
7.3.2 Europe Familial Amyloid Polyneuropathy Market Size by Application (2022-2027)
7.3.3 Europe Familial Amyloid Polyneuropathy Market Size by Application (2016-2027)
7.4 Europe Familial Amyloid Polyneuropathy Market Size by Country
7.4.1 Europe Familial Amyloid Polyneuropathy Market Size by Country (2016-2021)
7.4.2 Europe Familial Amyloid Polyneuropathy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Familial Amyloid Polyneuropathy Market Size (2016-2027)
8.2 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Type
8.2.1 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Type (2016-2027)
8.3 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Application
8.3.1 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Application (2016-2027)
8.4 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region
8.4.1 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Familial Amyloid Polyneuropathy Market Size (2016-2027)
9.2 Latin America Familial Amyloid Polyneuropathy Market Size by Type
9.2.1 Latin America Familial Amyloid Polyneuropathy Market Size by Type (2016-2021)
9.2.2 Latin America Familial Amyloid Polyneuropathy Market Size by Type (2022-2027)
9.2.3 Latin America Familial Amyloid Polyneuropathy Market Size by Type (2016-2027)
9.3 Latin America Familial Amyloid Polyneuropathy Market Size by Application
9.3.1 Latin America Familial Amyloid Polyneuropathy Market Size by Application (2016-2021)
9.3.2 Latin America Familial Amyloid Polyneuropathy Market Size by Application (2022-2027)
9.3.3 Latin America Familial Amyloid Polyneuropathy Market Size by Application (2016-2027)
9.4 Latin America Familial Amyloid Polyneuropathy Market Size by Country
9.4.1 Latin America Familial Amyloid Polyneuropathy Market Size by Country (2016-2021)
9.4.2 Latin America Familial Amyloid Polyneuropathy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Familial Amyloid Polyneuropathy Market Size (2016-2027)
10.2 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Type
10.2.1 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Type (2016-2027)
10.3 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Application
10.3.1 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Application (2016-2027)
10.4 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country
10.4.1 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Familial Amyloid Polyneuropathy Introduction
11.1.4 Pfizer Revenue in Familial Amyloid Polyneuropathy Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Familial Amyloid Polyneuropathy Introduction
11.2.4 GSK Revenue in Familial Amyloid Polyneuropathy Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Ionis
11.3.1 Ionis Company Details
11.3.2 Ionis Business Overview
11.3.3 Ionis Familial Amyloid Polyneuropathy Introduction
11.3.4 Ionis Revenue in Familial Amyloid Polyneuropathy Business (2016-2021)
11.3.5 Ionis Recent Development
11.4 Alnylam
11.4.1 Alnylam Company Details
11.4.2 Alnylam Business Overview
11.4.3 Alnylam Familial Amyloid Polyneuropathy Introduction
11.4.4 Alnylam Revenue in Familial Amyloid Polyneuropathy Business (2016-2021)
11.4.5 Alnylam Recent Development
11.5 Corino Therapeutics
11.5.1 Corino Therapeutics Company Details
11.5.2 Corino Therapeutics Business Overview
11.5.3 Corino Therapeutics Familial Amyloid Polyneuropathy Introduction
11.5.4 Corino Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2016-2021)
11.5.5 Corino Therapeutics Recent Development
11.6 Proclara Bioscience
11.6.1 Proclara Bioscience Company Details
11.6.2 Proclara Bioscience Business Overview
11.6.3 Proclara Bioscience Familial Amyloid Polyneuropathy Introduction
11.6.4 Proclara Bioscience Revenue in Familial Amyloid Polyneuropathy Business (2016-2021)
11.6.5 Proclara Bioscience Recent Development
11.7 Arcturus Therapeutics
11.7.1 Arcturus Therapeutics Company Details
11.7.2 Arcturus Therapeutics Business Overview
11.7.3 Arcturus Therapeutics Familial Amyloid Polyneuropathy Introduction
11.7.4 Arcturus Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2016-2021)
11.7.5 Arcturus Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Familial Amyloid Polyneuropathy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of FAP-I
Table 3. Key Players of FAP-II
Table 4. Key Players of FAP-III
Table 5. Key Players of FAP-IV
Table 6. Global Familial Amyloid Polyneuropathy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Familial Amyloid Polyneuropathy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Familial Amyloid Polyneuropathy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Familial Amyloid Polyneuropathy Market Share by Regions (2016-2021)
Table 10. Global Familial Amyloid Polyneuropathy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Familial Amyloid Polyneuropathy Market Share by Regions (2022-2027)
Table 12. Familial Amyloid Polyneuropathy Market Trends
Table 13. Familial Amyloid Polyneuropathy Market Drivers
Table 14. Familial Amyloid Polyneuropathy Market Challenges
Table 15. Familial Amyloid Polyneuropathy Market Restraints
Table 16. Global Familial Amyloid Polyneuropathy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Familial Amyloid Polyneuropathy Market Share by Players (2016-2021)
Table 18. Global Top Familial Amyloid Polyneuropathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Familial Amyloid Polyneuropathy as of 2020)
Table 19. Ranking of Global Top Familial Amyloid Polyneuropathy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Familial Amyloid Polyneuropathy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Familial Amyloid Polyneuropathy Product Solution and Service
Table 23. Date of Enter into Familial Amyloid Polyneuropathy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Familial Amyloid Polyneuropathy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Familial Amyloid Polyneuropathy Revenue Market Share by Type (2016-2021)
Table 27. Global Familial Amyloid Polyneuropathy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Familial Amyloid Polyneuropathy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Familial Amyloid Polyneuropathy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Familial Amyloid Polyneuropathy Revenue Market Share by Application (2016-2021)
Table 31. Global Familial Amyloid Polyneuropathy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Familial Amyloid Polyneuropathy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Familial Amyloid Polyneuropathy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Familial Amyloid Polyneuropathy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Familial Amyloid Polyneuropathy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Familial Amyloid Polyneuropathy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Familial Amyloid Polyneuropathy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Familial Amyloid Polyneuropathy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Familial Amyloid Polyneuropathy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Familial Amyloid Polyneuropathy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Familial Amyloid Polyneuropathy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Familial Amyloid Polyneuropathy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Familial Amyloid Polyneuropathy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Familial Amyloid Polyneuropathy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Familial Amyloid Polyneuropathy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Familial Amyloid Polyneuropathy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Familial Amyloid Polyneuropathy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Familial Amyloid Polyneuropathy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Familial Amyloid Polyneuropathy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Familial Amyloid Polyneuropathy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Familial Amyloid Polyneuropathy Product
Table 66. Pfizer Revenue in Familial Amyloid Polyneuropathy Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. GSK Company Details
Table 69. GSK Business Overview
Table 70. GSK Familial Amyloid Polyneuropathy Product
Table 71. GSK Revenue in Familial Amyloid Polyneuropathy Business (2016-2021) & (US$ Million)
Table 72. GSK Recent Development
Table 73. Ionis Company Details
Table 74. Ionis Business Overview
Table 75. Ionis Familial Amyloid Polyneuropathy Product
Table 76. Ionis Revenue in Familial Amyloid Polyneuropathy Business (2016-2021) & (US$ Million)
Table 77. Ionis Recent Development
Table 78. Alnylam Company Details
Table 79. Alnylam Business Overview
Table 80. Alnylam Familial Amyloid Polyneuropathy Product
Table 81. Alnylam Revenue in Familial Amyloid Polyneuropathy Business (2016-2021) & (US$ Million)
Table 82. Alnylam Recent Development
Table 83. Corino Therapeutics Company Details
Table 84. Corino Therapeutics Business Overview
Table 85. Corino Therapeutics Familial Amyloid Polyneuropathy Product
Table 86. Corino Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2016-2021) & (US$ Million)
Table 87. Corino Therapeutics Recent Development
Table 88. Proclara Bioscience Company Details
Table 89. Proclara Bioscience Business Overview
Table 90. Proclara Bioscience Familial Amyloid Polyneuropathy Product
Table 91. Proclara Bioscience Revenue in Familial Amyloid Polyneuropathy Business (2016-2021) & (US$ Million)
Table 92. Proclara Bioscience Recent Development
Table 93. Arcturus Therapeutics Company Details
Table 94. Arcturus Therapeutics Business Overview
Table 95. Arcturus Therapeutics Familial Amyloid Polyneuropathy Product
Table 96. Arcturus Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2016-2021) & (US$ Million)
Table 97. Arcturus Therapeutics Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Familial Amyloid Polyneuropathy Market Share by Type: 2020 VS 2027
Figure 2. FAP-I Features
Figure 3. FAP-II Features
Figure 4. FAP-III Features
Figure 5. FAP-IV Features
Figure 6. Global Familial Amyloid Polyneuropathy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Familial Amyloid Polyneuropathy Report Years Considered
Figure 10. Global Familial Amyloid Polyneuropathy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Familial Amyloid Polyneuropathy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Familial Amyloid Polyneuropathy Market Share by Regions: 2020 VS 2027
Figure 13. Global Familial Amyloid Polyneuropathy Market Share by Regions (2022-2027)
Figure 14. Global Familial Amyloid Polyneuropathy Market Share by Players in 2020
Figure 15. Global Top Familial Amyloid Polyneuropathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Familial Amyloid Polyneuropathy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Familial Amyloid Polyneuropathy Revenue in 2020
Figure 17. Global Familial Amyloid Polyneuropathy Revenue Market Share by Type (2016-2021)
Figure 18. Global Familial Amyloid Polyneuropathy Revenue Market Share by Type (2022-2027)
Figure 19. North America Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Familial Amyloid Polyneuropathy Market Share by Type (2016-2027)
Figure 21. North America Familial Amyloid Polyneuropathy Market Share by Application (2016-2027)
Figure 22. North America Familial Amyloid Polyneuropathy Market Share by Country (2016-2027)
Figure 23. United States Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Familial Amyloid Polyneuropathy Market Share by Type (2016-2027)
Figure 27. Europe Familial Amyloid Polyneuropathy Market Share by Application (2016-2027)
Figure 28. Europe Familial Amyloid Polyneuropathy Market Share by Country (2016-2027)
Figure 29. Germany Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Familial Amyloid Polyneuropathy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Familial Amyloid Polyneuropathy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Familial Amyloid Polyneuropathy Market Share by Region (2016-2027)
Figure 39. China Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Familial Amyloid Polyneuropathy Market Share by Type (2016-2027)
Figure 47. Latin America Familial Amyloid Polyneuropathy Market Share by Application (2016-2027)
Figure 48. Latin America Familial Amyloid Polyneuropathy Market Share by Country (2016-2027)
Figure 49. Mexico Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Familial Amyloid Polyneuropathy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Familial Amyloid Polyneuropathy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Familial Amyloid Polyneuropathy Market Share by Country (2016-2027)
Figure 55. Turkey Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Familial Amyloid Polyneuropathy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2016-2021)
Figure 59. GSK Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2016-2021)
Figure 60. Ionis Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2016-2021)
Figure 61. Alnylam Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2016-2021)
Figure 62. Corino Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2016-2021)
Figure 63. Proclara Bioscience Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2016-2021)
Figure 64. Arcturus Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global Familial Amyloid Polyneuropathy Market Size, Status and Forecast 2021-2027
QYR2104Z2314 2021年4月 96Pages
QYResearch社発行の本調査資料では、家族性アミロイド多発神経障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（FAP-I、FAP-II、FAP-III、FAP-IV）、用途別市場規模（病院・クリニック、その他）、主要地域別市場規模（北...

世界のトランスサイレチンアミロイド心筋症（ATTR-CM）治療市場規模・現状・予測（2021年-2027年）

Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5731 2021年4月 91Pages
QYResearch社発行の本調査資料では、トランスサイレチンアミロイド心筋症（ATTR-CM）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トランスサイレチン安定剤、非ステロイド性抗炎症薬（NSAID）、RNAi療法、その他）、用途別市...

世界の慢性炎症性脱髄性多発神経炎（CIDP）市場規模・現状・予測（2021年-2027年）

Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size, Status and Forecast 2021-2027
QYR2104Z1316 2021年4月 99Pages
QYResearch社発行の本調査資料では、慢性炎症性脱髄性多発神経炎（CIDP）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド療法、IVIG治療、血漿交換療法、免疫抑制薬療法、免疫調節剤療法、その他）、用途別市場規模（病院...

世界の周期的発熱症候群市場規模・現状・予測（2021年-2027年）

Global Periodic Fever Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z4515 2021年4月 99Pages
QYResearch社発行の本調査資料では、周期的発熱症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（高IgD症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）、用途別市場規模（病院、ドラッグス...

世界の自律神経失調症治療薬市場規模・現状・予測（2021年-2027年）

Global Dysautonomia Treatment Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z2020 2021年4月 91Pages
QYResearch社発行の本調査資料では、自律神経失調症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フルドロコルチゾン、ミドドリン、ベータ遮断薬、ピリドスチグミン、IV生理食塩水、その他）、用途別市場規模（神経心原性失神（NCS）、...

世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年）

Global Alzheimer’s Disease Diagnostic Market Size, Status and Forecast 2021-2027
QYR2104Z0274 2021年4月 97Pages
QYResearch社発行の本調査資料では、アルツハイマー病診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（神経系検査、遺伝子検査、ミニメンタルステート検査（Mmse）、脳画像）、用途別市場規模（早期発症型アルツハイマー病、家族性アルツハイ...

世界のクロファラビン市場規模・現状・予測（2021年-2027年）

Global Clofarabine Market Size, Status and Forecast 2021-2027
QYR2104Z1384 2021年4月 99Pages
QYResearch社発行の本調査資料では、クロファラビンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エボルトラ、クロファラビン）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Market Size, Status and Forecast 2021-2027
QYR2104Z0094 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年）

Global Micafungin Sodium for Injection Market Size, Status and Forecast 2021-2027
QYR2104Z3743 2021年4月 97Pages
QYResearch社発行の本調査資料では、注射用ミカファンギンナトリウムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（50mg使い捨てバイアル、100mg使い捨てバイアル）、用途別市場規模（カンジダ血症、呼吸器真菌症、胃腸真菌症）、主要地域...

世界の家族性アミロイド多発神経障害市場規模・現状・予測（2021年-2027年） Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the deposition of protein and/or amyloid fibrils around the peripheral nerves and in various tissues, including the heart muscle. Globally, development of new dru…
世界のトランスサイレチンアミロイド心筋症（ATTR-CM）治療市場規模・現状・予測（2021年-2027年） Transthyretin Amyloidosis (ATTR) is a progressive and severe orphan disease. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of transthyretin amyloidosis (ATTR) that affects the heart and leads to restrictive cardiomyopathy and progressive heart failure. It is generally a rare, underdiagnos…
世界の慢性炎症性脱髄性多発神経炎（CIDP）市場規模・現状・予測（2021年-2027年） Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune motor sensory peripheral neuropathy with chronic demyelination of the proximal peripheral nerves as the main lesion. It belongs to chronic acquired demyelinating multiple neuropathy (ADP), the most common type of CADP, and pre…
世界の周期的発熱症候群市場規模・現状・予測（2021年-2027年） Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation. The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. Market …
世界の自律神経失調症治療薬市場規模・現状・予測（2021年-2027年） Dysautonomia (Autonomic Dysfunction) is a disorder of autonomic nervous system. Factors driving global demand for Dysautonomia are increasing awareness amongst people, government initiatives and increased diagnosis. Market Analysis and Insights: Global Dysautonomia Treatment Drugs Market The global …